← Back to Search

Continuous Glucose Monitor

Continuous glucose monitor for Type 2 Diabetes

N/A
Waitlist Available
Led By Elizabeth Phillips, PharmD, CACP
Research Sponsored by Chieh Chen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is a pilot study to generate interest in the FreeStyle Libre 2 sensor in patients with type 2 diabetes. The trial's objectives are to determine if there is a difference in diabetes control and satisfaction with glucose monitoring, and to compare the frequency of hypoglycemia before and after management with the sensor.

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in percent time in range of 70-180mg/dL (%TIR)
Secondary outcome measures
Change in %CV
Change in %TAR >180mg/dL
Change in %TAR >250mg/dL
+18 more

Side effects data

From 2009 Phase 3 trial • 451 Patients • NCT00406133
11%
Severe Hypoglycemia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Secondary Cohort Control Group
Primary Cohort RT-CGM Group
Primary Cohort Control Group
Secondary Cohort RT-CGM Group

Trial Design

1Treatment groups
Experimental Treatment
Group I: Continuous Glucose MonitorExperimental Treatment1 Intervention
Adult patients with Type 2 Diabetes on any anti-diabetic regimen utilizing continuous glucose monitors for 3 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Continuous glucose monitor
2006
Completed Phase 3
~640

Find a Location

Who is running the clinical trial?

St. John Fisher CollegeUNKNOWN
Chieh ChenLead Sponsor
Elizabeth Phillips, PharmD, CACPPrincipal InvestigatorSt. John Fisher College

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being accepted for this trial?

"As per the clinicaltrials.gov website, this investigation is no longer enrolling patients. It was initially posted on January 24th 2022 and last updated on May 3rd 2022. However, notwithstanding this trial's closure there are still 1443 other studies actively seeking participants at present."

Answered by AI

Who else is applying?

What state do they live in?
New York
Tennessee
How old are they?
18 - 65
What site did they apply to?
Upstate Health Care Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Evaluation of a Single Center Expansion of Continuous Glucose Monitor Access in Patients With Type 2 Diabetes
Chieh Chen 2022. "Evaluation of a Single Center Expansion of Continuous Glucose Monitor Access in Patients With Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05200390.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top